Skip to main content
Erschienen in:

25.10.2019 | Parkinson-Krankheit | Leitthema

Remote-Messung bei idiopathischem Parkinson-Syndrom

Entwicklungen in Diagnose, Monitoring und Therapie

verfasst von: Dr. U. Kleinholdermann, J. Melsbach, D. J. Pedrosa

Erschienen in: Der Nervenarzt | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Zusammenfassung

Das idiopathische Parkinson-Syndrom (iPS) ist eine progrediente neurodegenerative Erkrankung, die vor allem die Beweglichkeit der Betroffenen einschränkt. Im Verlauf der Erkrankung treten häufig starke Schwankungen der Symptome auf, die eine adäquate Therapie erschweren. In dieser Literaturübersicht stellen wir aktuelle Ansätze zur Nutzung moderner, insbesondere mobiler Technologien bei Diagnose, Verlaufsbeurteilung und Therapie des iPS vor. Auch wenn aktuell noch keine anwendungsreifen Hilfsmittel verfügbar sind, birgt die Entwicklung viel Potenzial zur Verbesserung der Versorgung von Patienten mit iPS.
Literatur
1.
Zurück zum Zitat Abdolahi A, Bull MT, Darwin KC et al (2016) A feasibility study of conducting the Montreal Cognitive Assessment remotely in individuals with movement disorders. Health Informatics J 22:304–311CrossRef Abdolahi A, Bull MT, Darwin KC et al (2016) A feasibility study of conducting the Montreal Cognitive Assessment remotely in individuals with movement disorders. Health Informatics J 22:304–311CrossRef
2.
Zurück zum Zitat Abdolahi A, Scoglio N, Killoran A et al (2013) Potential reliability and validity of a modified version of the Unified Parkinson’s Disease Rating Scale that could be administered remotely. Parkinsonism Relat Disord 19:218–221CrossRef Abdolahi A, Scoglio N, Killoran A et al (2013) Potential reliability and validity of a modified version of the Unified Parkinson’s Disease Rating Scale that could be administered remotely. Parkinsonism Relat Disord 19:218–221CrossRef
4.
Zurück zum Zitat Augustine EF, Pérez A, Dhall R et al (2015) Sex differences in clinical features of early, treated parkinson’s disease. Plos One 10:e133002CrossRef Augustine EF, Pérez A, Dhall R et al (2015) Sex differences in clinical features of early, treated parkinson’s disease. Plos One 10:e133002CrossRef
5.
Zurück zum Zitat Barroso Júnior MC, Esteves GP, Nunes TP et al (2011) A telemedicine instrument for remote evaluation of tremor: design and initial applications in fatigue and patients with Parkinson’s disease. Biomed Eng Online 10:14CrossRef Barroso Júnior MC, Esteves GP, Nunes TP et al (2011) A telemedicine instrument for remote evaluation of tremor: design and initial applications in fatigue and patients with Parkinson’s disease. Biomed Eng Online 10:14CrossRef
6.
Zurück zum Zitat Beck CA, Beran DB, Biglan KM et al (2017) National randomized controlled trial of virtual house calls for Parkinson disease. Neurology 89:1152–1161CrossRef Beck CA, Beran DB, Biglan KM et al (2017) National randomized controlled trial of virtual house calls for Parkinson disease. Neurology 89:1152–1161CrossRef
7.
Zurück zum Zitat Block VAJ, Pitsch E, Tahir P et al (2016) Remote physical activity monitoring in neurological disease: a systematic review. PLoS One 11:e154335CrossRef Block VAJ, Pitsch E, Tahir P et al (2016) Remote physical activity monitoring in neurological disease: a systematic review. PLoS One 11:e154335CrossRef
8.
Zurück zum Zitat van den Bussche H, Schön G, Kolonko T et al (2011) Patterns of ambulatory medical care utilization in elderly patients with special reference to chronic diseases and multimorbidity—results from a claims data based observational study in Germany. BMC Geriatr 11:54CrossRef van den Bussche H, Schön G, Kolonko T et al (2011) Patterns of ambulatory medical care utilization in elderly patients with special reference to chronic diseases and multimorbidity—results from a claims data based observational study in Germany. BMC Geriatr 11:54CrossRef
9.
Zurück zum Zitat Neto CE, Bot BM, Perumal T et al (2016) Personalized hypothesis tests for detecting medication response in Parkinson disease patients using iphone sensor data. Pac Symp Biocomput 21:273–284 Neto CE, Bot BM, Perumal T et al (2016) Personalized hypothesis tests for detecting medication response in Parkinson disease patients using iphone sensor data. Pac Symp Biocomput 21:273–284
10.
Zurück zum Zitat Delrobaei M, Memar S, Pieterman M et al (2018) Towards remote monitoring of Parkinson’s disease tremor using wearable motion capture systems. J Neurol Sci 384:38–45CrossRef Delrobaei M, Memar S, Pieterman M et al (2018) Towards remote monitoring of Parkinson’s disease tremor using wearable motion capture systems. J Neurol Sci 384:38–45CrossRef
11.
Zurück zum Zitat Djurić-Jovičić M, Petrović I, Ječmenica-Lukić M et al (2016) Finger tapping analysis in patients with Parkinson’s disease and atypical parkinsonism. J Clin Neurosci 30:49–55CrossRef Djurić-Jovičić M, Petrović I, Ječmenica-Lukić M et al (2016) Finger tapping analysis in patients with Parkinson’s disease and atypical parkinsonism. J Clin Neurosci 30:49–55CrossRef
12.
Zurück zum Zitat Eggers C, Pedrosa DJ, Kahraman D et al (2012) Parkinson subtypes progress differently in clinical course and imaging pattern. PLoS One 7:e46813CrossRef Eggers C, Pedrosa DJ, Kahraman D et al (2012) Parkinson subtypes progress differently in clinical course and imaging pattern. PLoS One 7:e46813CrossRef
13.
Zurück zum Zitat Fahn SER (1987) The Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (Hrsg) Recent Developments in Parkinson’s Disease. McMellam Health Care Information, Florham Park, S 153–163 Fahn SER (1987) The Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (Hrsg) Recent Developments in Parkinson’s Disease. McMellam Health Care Information, Florham Park, S 153–163
14.
Zurück zum Zitat Fazekas C, Vörös T, Keresztényi Z et al (2002) Computer aided interactive remote diagnosis of Parkinsonians. Stud Health Technol Inform 90:572–576PubMed Fazekas C, Vörös T, Keresztényi Z et al (2002) Computer aided interactive remote diagnosis of Parkinsonians. Stud Health Technol Inform 90:572–576PubMed
15.
Zurück zum Zitat Gandolfi M, Geroin C, Dimitrova E et al (2017) Virtual reality telerehabilitation for postural instability in parkinson’s disease: a multicenter, single-blind, randomized, controlled trial. Biomed Res Int 2017:7962826CrossRef Gandolfi M, Geroin C, Dimitrova E et al (2017) Virtual reality telerehabilitation for postural instability in parkinson’s disease: a multicenter, single-blind, randomized, controlled trial. Biomed Res Int 2017:7962826CrossRef
16.
Zurück zum Zitat Gonçalves H, Moreira R, Rodrigues A, Santos C (2018) Finding parameters around the abdomen for a vibrotactile system: healthy and patients with parkinson’s disease. J Med Syst 42:232CrossRef Gonçalves H, Moreira R, Rodrigues A, Santos C (2018) Finding parameters around the abdomen for a vibrotactile system: healthy and patients with parkinson’s disease. J Med Syst 42:232CrossRef
18.
Zurück zum Zitat Heinzel S, Kasten M, Behnke S et al (2018) Age- and sex-related heterogeneity in prodromal Parkinson’s disease. Mov Disord 33:1025–1027CrossRef Heinzel S, Kasten M, Behnke S et al (2018) Age- and sex-related heterogeneity in prodromal Parkinson’s disease. Mov Disord 33:1025–1027CrossRef
19.
Zurück zum Zitat Heldman DA, Giuffrida JP, Cubo E (2016) Wearable sensors for advanced therapy referral in parkinson’s disease. J Parkinsons Dis 6:631–638CrossRef Heldman DA, Giuffrida JP, Cubo E (2016) Wearable sensors for advanced therapy referral in parkinson’s disease. J Parkinsons Dis 6:631–638CrossRef
20.
Zurück zum Zitat Kassavetis P, Saifee TA, Roussos G et al (2016) Developing a tool for remote digital assessment of parkinson’s disease. Mov Disord Clin Pract 3:59–64CrossRef Kassavetis P, Saifee TA, Roussos G et al (2016) Developing a tool for remote digital assessment of parkinson’s disease. Mov Disord Clin Pract 3:59–64CrossRef
21.
Zurück zum Zitat Lipsmeier F, Taylor KI, Kilchenmann T et al (2018) Evaluation of smartphone-based testing to generate exploratory outcome measures in a phase 1 Parkinson’s disease clinical trial. Mov Disord 33:1287–1297CrossRef Lipsmeier F, Taylor KI, Kilchenmann T et al (2018) Evaluation of smartphone-based testing to generate exploratory outcome measures in a phase 1 Parkinson’s disease clinical trial. Mov Disord 33:1287–1297CrossRef
22.
Zurück zum Zitat Macleod AD, Taylor KSM, Counsell CE (2014) Mortality in Parkinson’s disease: a systematic review and meta-analysis. Mov Disord 29:1615–1622CrossRef Macleod AD, Taylor KSM, Counsell CE (2014) Mortality in Parkinson’s disease: a systematic review and meta-analysis. Mov Disord 29:1615–1622CrossRef
23.
Zurück zum Zitat Maier F, Prigatano GP (2017) Impaired self-awareness of motor disturbances in parkinson’s disease. Arch Clin Neuropsychol 32:802–809CrossRef Maier F, Prigatano GP (2017) Impaired self-awareness of motor disturbances in parkinson’s disease. Arch Clin Neuropsychol 32:802–809CrossRef
24.
Zurück zum Zitat Mamun KAA, Alhussein M, Sailunaz K, Islam MS (2017) Cloud based framework for Parkinson’s disease diagnosis and monitoring system for remote healthcare applications. Future Gener Comput Syst 66:36–47CrossRef Mamun KAA, Alhussein M, Sailunaz K, Islam MS (2017) Cloud based framework for Parkinson’s disease diagnosis and monitoring system for remote healthcare applications. Future Gener Comput Syst 66:36–47CrossRef
25.
Zurück zum Zitat Martinez-Martin P, Rodriguez-Blazquez C, Forjaz MJ, Kurtis MM (2015) Impact of pharmacotherapy on quality of life in patients with parkinson’s disease. Cns Drugs 29:397–413CrossRef Martinez-Martin P, Rodriguez-Blazquez C, Forjaz MJ, Kurtis MM (2015) Impact of pharmacotherapy on quality of life in patients with parkinson’s disease. Cns Drugs 29:397–413CrossRef
26.
Zurück zum Zitat Mitsi G, Mendoza EU, Wissel BD et al (2017) Biometric digital health technology for measuring motor function in parkinson’s disease: results from a feasibility and patient satisfaction study. Front Neurol 8:273CrossRef Mitsi G, Mendoza EU, Wissel BD et al (2017) Biometric digital health technology for measuring motor function in parkinson’s disease: results from a feasibility and patient satisfaction study. Front Neurol 8:273CrossRef
27.
Zurück zum Zitat Piro NE, Piro LK, Kassubek J, Blechschmidt-Trapp RA (2016) Analysis and visualization of 3D motion data for UPDRS rating of patients with parkinson’s disease. Sensors, BaselCrossRef Piro NE, Piro LK, Kassubek J, Blechschmidt-Trapp RA (2016) Analysis and visualization of 3D motion data for UPDRS rating of patients with parkinson’s disease. Sensors, BaselCrossRef
28.
Zurück zum Zitat Postuma RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30:1591–1601CrossRef Postuma RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30:1591–1601CrossRef
29.
Zurück zum Zitat van Rooden SM, Heiser WJ, Kok JN et al (2010) The identification of Parkinson’s disease subtypes using cluster analysis: a systematic review. Mov Disord 25:969–978CrossRef van Rooden SM, Heiser WJ, Kok JN et al (2010) The identification of Parkinson’s disease subtypes using cluster analysis: a systematic review. Mov Disord 25:969–978CrossRef
30.
Zurück zum Zitat Rovini E, Maremmani C, Cavallo F (2017) How wearable sensors can support parkinson’s disease diagnosis and treatment: a systematic review. Front Neurosci 11:555CrossRef Rovini E, Maremmani C, Cavallo F (2017) How wearable sensors can support parkinson’s disease diagnosis and treatment: a systematic review. Front Neurosci 11:555CrossRef
31.
Zurück zum Zitat Stillerova T, Liddle J, Gustafsson L et al (2016) Could everyday technology improve access to assessments? A pilot study on the feasibility of screening cognition in people with Parkinson’s disease using the Montreal Cognitive Assessment via Internet videoconferencing. Aust Occup Ther J 63:373–380CrossRef Stillerova T, Liddle J, Gustafsson L et al (2016) Could everyday technology improve access to assessments? A pilot study on the feasibility of screening cognition in people with Parkinson’s disease using the Montreal Cognitive Assessment via Internet videoconferencing. Aust Occup Ther J 63:373–380CrossRef
32.
Zurück zum Zitat Südmeyer M, Wojtecki L, Schnitzler A (2012) Integrierte Versorgung des Morbus Parkinson. Akt Neurol 39:475–479CrossRef Südmeyer M, Wojtecki L, Schnitzler A (2012) Integrierte Versorgung des Morbus Parkinson. Akt Neurol 39:475–479CrossRef
33.
Zurück zum Zitat Swalwell C, Pachana NA, Dissanayaka NN (2018) Remote delivery of psychological interventions for Parkinson’s disease. Int Psychogeriatr 30:1783–1795CrossRef Swalwell C, Pachana NA, Dissanayaka NN (2018) Remote delivery of psychological interventions for Parkinson’s disease. Int Psychogeriatr 30:1783–1795CrossRef
34.
Zurück zum Zitat Temlett JA, Thompson PD (2006) Reasons for admission to hospital for Parkinson’s disease. Intern Med J 36:524–526CrossRef Temlett JA, Thompson PD (2006) Reasons for admission to hospital for Parkinson’s disease. Intern Med J 36:524–526CrossRef
35.
Zurück zum Zitat Thorp JE, Adamczyk PG, Ploeg H‑L, Pickett KA (2018) Monitoring motor symptoms during activities of daily living in individuals with parkinson’s disease. Front Neurol 9:1036CrossRef Thorp JE, Adamczyk PG, Ploeg H‑L, Pickett KA (2018) Monitoring motor symptoms during activities of daily living in individuals with parkinson’s disease. Front Neurol 9:1036CrossRef
Metadaten
Titel
Remote-Messung bei idiopathischem Parkinson-Syndrom
Entwicklungen in Diagnose, Monitoring und Therapie
verfasst von
Dr. U. Kleinholdermann
J. Melsbach
D. J. Pedrosa
Publikationsdatum
25.10.2019
Verlag
Springer Medizin
Erschienen in
Der Nervenarzt / Ausgabe 12/2019
Print ISSN: 0028-2804
Elektronische ISSN: 1433-0407
DOI
https://doi.org/10.1007/s00115-019-00818-7

Weitere Artikel der Ausgabe 12/2019

Der Nervenarzt 12/2019 Zur Ausgabe

Einführung zum Thema

Patientenmonitoring 4.0

01.10.2024 | Sammlung

Passend zum Thema